Pulse Biosciences (PLSE) insider buying

Healthcare · Medical Instruments & Supplies · Market cap $3.7B

3 open-market purchases of PLSE by Pulse Biosciences's executives and directors since September 2025, worth $608,072 in total, from SEC Form 4 filings.

The most recent: Liane Rae Teplitsky, Chief Operating Officer bought $50,000 on September 1, 2026.

The biggest buyer over the period is Robert W Duggan: 1 purchase, $508,101.

By year

YearPurchasesValue
20262$99,971
20251$508,101

Biggest buyers

InsiderBuysValue
Robert W Duggan
1$508,101
Liane Rae Teplitsky
Chief Operating Officer		2$99,971

Every purchase

Newest first. From SEC Form 4 filings. Insider buying across the market.

DateInsiderSharesPriceValueFiling
Sep 1, 2026 Liane Rae Teplitsky
Chief Operating Officer		 1,001$49.95$50,000 Form 4
Aug 31, 2026 Liane Rae Teplitsky
Chief Operating Officer		 1,024$48.80$49,971 Form 4
Sep 10, 2025 Robert W Duggan
 34,659$14.66$508,101 Form 4
Every line, every quarterThe deep dive has fifteen-plus years of statements, quarterly results, charts and valuation models for PLSE.
Open PLSE in Investingly

Questions

Are Pulse Biosciences insiders buying the stock?

3 open-market purchases of PLSE by Pulse Biosciences's executives and directors since September 2025, worth $608,072 in total, from SEC Form 4 filings. The most recent: Liane Rae Teplitsky, Chief Operating Officer bought $50,000 on September 1, 2026.

What counts as insider buying here?

Open-market purchases (Form 4 code P) by officers and directors. Option exercises, grants and purchases by 10% owners are left out.

From Pulse Biosciences's annual reports filed with the SEC (XBRL data), standardised by Investingly. Information only, not investment advice.